Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices
The 2018 statement incorporates guidance for vaccination and testing of people at occupational risk for hepatitis B virus exposure (such as healthcare providers), including persons vaccinated as infants or adolescents who now test negative for anti-HBs.
The 2018 adult immunization schedule has also been approved by the American College of Physicians, the American Academy of Family Physicians, the American College of Obstetricians and Gynecologists, and the American College of Nurse-Midwives. Read On.
This guide helps parents and caregivers learn about the role vaccines play in helping keep children healthy and includes information on preparing for an immunization office visit. The color booklet includes a glossary and list of resources and is illustrated with children’s artwork. Read online, download, or order a printed booklet. Centers for Disease Control and Prevention
Sponsored through a grant from the NJ Department of Health, NJAFP has created a series of patient education videos designed to dispell the myths surrounding vaccines. These short videos are free to download and use in your waiting room or exam room. Learn more here!
The NJAAP is joining states in AAP District 3 in a quality improvement project to increase HPV immunization rates and prevent HPV cancers in the state. Webinars and other materials are archived here for all participating chapters and practices. For more information, contact Aldina M. Hovde, MSW at firstname.lastname@example.org or 609-842-0014, ext 123.
Partnerships & Funding
Preventing HPV Cancers Kick-Off
New ACIP Recommendations for HPV Vaccination
Overview of Quality Improvement Science and Networking
Talking to Parents About HPV Vaccine: University of Kansas Cancer Center and Children’s Mercy
According to the annual vaccination report, only 33.3% of eligible adolescents received the CDC-recommended MenACWY booster vaccination to help protect against meningococcal meningitis, as compared to 81.3% of those teens who received the recommended first vaccination.
The second booster vaccination, recommended at 16 years of age, is important because data suggest that protection from the first dose wanes within 5 years in approximately half of immunized teens.